P. Bunn

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

M. Ladanyi, A. Iafrate, M. Kris, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.

Erin L. Schenk, P. Bunn, R. Doebele, 2019, Clinical lung cancer.

Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents.

F. Hirsch, P. Bunn, W. Franklin, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?

M. Krasnow, J. Minna, P. Massion, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas

F. Hirsch, P. Bunn, W. Franklin, 2002, British Journal of Cancer.

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients

F. Cappuzzo, F. Hirsch, P. Bunn, 2005, British Journal of Cancer.

Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non–small Cell Lung Cancer

Kenneth L. Jones, P. Bunn, M. Varella‐Garcia, 2018, Clinical Cancer Research.

Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer

P. Bunn, M. Varella‐Garcia, R. Doebele, 2013, PloS one.

Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study.

Y. Miller, F. Hirsch, P. Bunn, 2001, Journal of the National Cancer Institute.

Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

P. Bunn, D. Ahnen, C. Fenoglio-Preiser, 1998, Cancer research.

Prevalence, molecular markers, and outcome of bronchial squamous carcinoma in situ in high‐risk subjects

Y. Miller, S. Jonsson, G. Oskarsdóttir, 2023, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.